Article
Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer
5 May 2023
Abstract excerpt
BACKGROUND: The aim of this study was to construct a predictive signature integrating tumour-mutation- and copy-number-variation-associated features using machine learning to precisely predict early relapse and survival in patients with resected stage I-II pancreatic ductal adenocarcinoma. METHODS: Patients with microscopically confirmed stage I-II pancreatic ductal adenocarcinoma undergoing R0 resection at the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
